1. Diastolic Cardiac Function Improvement by Liraglutide Is Mainly Body Weight Reduction Dependent but Independently Contributes to B-Type Natriuretic Peptide Reduction in Patients with Type 2 Diabetes with Preserved Ejection Fraction. (28th March 2021) Authors: Yagi, Kunimasa; Imamura, Teruhiko; Tada, Hayato; Chujo, Daisuke; Liu, Jianhui; Shima, Yuuki; Ohbatake, Azusa; Miyamoto, Yukiko; Okazaki, Satoko; Ito, Naoko; Nakano, Kaoru; Shikata, Masataka; Enkaku, Asako; Takikawa, Akiko; Honoki, Hisae; Fujisaka, Shiho; Origasa, Hideki; Tobe, Kazuyuki Other Names: Fiorina Paolo Academic Editor. Journal: Journal of diabetes research Issue: Volume 2021(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗